JIC
DGX icon

Johnson Investment Counsel’s Quest Diagnostics DGX Stock Holding History

Johnson Investment Counsel’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Sell
12,820
-3,400
-21% -$667K 0.02% 273
2026
Q1 		$3.18M Buy
16,220
+93
+0.6% +$18.1K 0.03% 231
2025
Q4 		$2.8M Hold
16,127
– – 0.02% 249
2025
Q3 		$3.07M Hold
16,127
– – 0.03% 231
2025
Q2 		$2.9M Sell
16,127
-159
-1% -$27.6K 0.03% 231
2025
Q1 		$2.76M Buy
16,286
+3,330
+26% +$547K 0.03% 232
2024
Q4 		$1.95M Hold
12,956
– – 0.02% 293
2024
Q3 		$2.01M Buy
12,956
+320
+3% +$47.8K 0.02% 288
2024
Q2 		$1.73M Buy
12,636
+3,500
+38% +$479K 0.02% 293
2024
Q1 		$1.22M Sell
9,136
-49
-0.5% -$6.36K 0.01% 356
2023
Q4 		$1.27M Buy
9,185
+4,620
+101% +$607K 0.01% 333
2023
Q3 		$556K Buy
4,565
+40
+0.9% +$5.33K 0.01% 446
2023
Q2 		$636K Buy
4,525
+93
+2% +$12.8K 0.01% 429
2023
Q1 		$627K Buy
4,432
+115
+3% +$16.5K 0.01% 423
2022
Q4 		$675K Sell
4,317
-37
-0.8% -$5.32K 0.01% 400
2022
Q3 		$534K Buy
4,354
+37
+0.9% +$4.87K 0.01% 424
2022
Q2 		$574K Buy
4,317
+400
+10% +$54.5K 0.01% 415
2022
Q1 		$536K Buy
3,917
+410
+12% +$57.1K 0.01% 451
2021
Q4 		$607K Buy
3,507
+456
+15% +$69.4K 0.01% 429
2021
Q3 		$443K Hold
3,051
– – 0.01% 470
2021
Q2 		$403K Sell
3,051
-114
-4% -$14.9K 0.01% 481
2021
Q1 		$406K Buy
+3,165
New +$390K 0.01% 456
2019
Q2 		– Sell
-2,683
Closed -$241K – 608
2019
Q1 		$241K Buy
2,683
+32
+1% +$2.77K 0.01% 551
2018
Q4 		$220K Buy
+2,651
New +$249K 0.01% 545

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Johnson Investment Counsel's DGX Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Quest Diagnostics (DGX) stake by 21% in Q2 2026, selling an estimated $667K and leaving 12,820 shares worth $2.72M. The position accounts for 0.02% of the portfolio, ranked #273.

Johnson Investment Counsel first reported a position in DGX in Q4 2018 and has held it in 24 quarters since. The position peaked at $3.18M in Q1 2026. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Johnson Investment Counsel held 12,820 shares of Quest Diagnostics worth $2.72M as of Q2 2026.
  • Johnson Investment Counsel sold 3,400 Quest Diagnostics shares in Q2 2026, an estimated $667K.
  • Quest Diagnostics made up 0.02% of Johnson Investment Counsel's portfolio in Q2 2026, its #273 holding.
  • Johnson Investment Counsel first reported a position in Quest Diagnostics in Q4 2018 and has held it in 24 quarters since.
  • Johnson Investment Counsel's Quest Diagnostics position peaked at $3.18M in Q1 2026.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.